BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 11387010)

  • 1. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
    Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
    Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
    Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
    Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.
    Albertini JJ; Lyman GH; Cox C; Yeatman T; Balducci L; Ku N; Shivers S; Berman C; Wells K; Rapaport D; Shons A; Horton J; Greenberg H; Nicosia S; Clark R; Cantor A; Reintgen DS
    JAMA; 1996 Dec; 276(22):1818-22. PubMed ID: 8946902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer.
    Ramjeesingh R; Quan ML; Gardner S; Holloway CM
    Can J Surg; 2009 Feb; 52(1):23-30. PubMed ID: 19234648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer.
    Nwariaku FE; Euhus DM; Beitsch PD; Clifford E; Erdman W; Mathews D; Albores-Saavedra J; Leitch MA; Peters GN
    Am J Surg; 1998 Dec; 176(6):529-31. PubMed ID: 9926784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
    Giuliano AE; Dale PS; Turner RR; Morton DL; Evans SW; Krasne DL
    Ann Surg; 1995 Sep; 222(3):394-9; discussion 399-401. PubMed ID: 7677468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.
    Turner RR; Ollila DW; Krasne DL; Giuliano AE
    Ann Surg; 1997 Sep; 226(3):271-6; discussion 276-8. PubMed ID: 9339933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma.
    Cserni G; Bianchi S; Vezzosi V; Peterse H; Sapino A; Arisio R; Reiner-Concin A; Regitnig P; Bellocq JP; Marin C; Bori R; Penuela JM; Iturriagagoitia AC
    J Clin Pathol; 2006 May; 59(5):518-22. PubMed ID: 16497870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection.
    Fournier K; Schiller A; Perry RR; Laronga C
    Ann Surg; 2004 Jun; 239(6):859-63; discussion 863-5. PubMed ID: 15166965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between sentinel lymph node biopsy and non-sentinel lymph node metastasis in patients with cN0 breast carcinoma: comparison of invasive ductal carcinoma and invasive lobular carcinoma.
    Cipolla C; Lupo S; Grassi N; Tutino G; Greco M; Eleonora D; Gebbia V; Valerio MR
    World J Surg Oncol; 2024 Apr; 22(1):100. PubMed ID: 38627759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.
    Cantin J; Scarth H; Levine M; Hugi M;
    CMAJ; 2001 Jul; 165(2):166-73. PubMed ID: 11501455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
    ; Crystal JS; Thompson JF; Hyngstrom J; Caracò C; Zager JS; Jahkola T; Bowles TL; Pennacchioli E; Beitsch PD; Hoekstra HJ; Moncrieff M; Ingvar C; van Akkooi A; Sabel MS; Levine EA; Agnese D; Henderson M; Dummer R; Neves RI; Rossi CR; Kane JM; Trocha S; Wright F; Byrd DR; Matter M; Hsueh EC; MacKenzie-Ross A; Kelley M; Terheyden P; Huston TL; Wayne JD; Neuman H; Smithers BM; Ariyan CE; Desai D; Gershenwald JE; Schneebaum S; Gesierich A; Jacobs LK; Lewis JM; McMasters KM; O'Donoghue C; van der Westhuizen A; Sardi A; Barth R; Barone R; McKinnon JG; Slingluff CL; Farma JM; Schultz E; Scheri RP; Vidal-Sicart S; Molina M; Testori AAE; Foshag LJ; Van Kreuningen L; Wang HJ; Sim MS; Scolyer RA; Elashoff DE; Cochran AJ; Faries MB
    JAMA Surg; 2022 Sep; 157(9):835-842. PubMed ID: 35921122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial.
    Caudle AS; Yang WT; Mittendorf EA; Black DM; Hwang R; Hobbs B; Hunt KK; Krishnamurthy S; Kuerer HM
    JAMA Surg; 2015 Feb; 150(2):137-43. PubMed ID: 25517573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is a significant risk factor for non-sentinel nodal metastasis in breast cancer patients with sentinel lymph node (SLN)-positive breast cancer: a cross-sectional study.
    Wei C; Deng Y; Wei S; Huang Z; Xie Y; Xu J; Dong L; Zou Q; Yang J
    World J Surg Oncol; 2023 Dec; 21(1):386. PubMed ID: 38097994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary therapy of malignant melanomas: sentinel lymphadenectomy.
    Bachter D; Balda BR; Vogt H; Büchels H
    Int J Dermatol; 1998 Apr; 37(4):278-82. PubMed ID: 9585901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer.
    Lynch MA; Jackson J; Kim JA; Leeming RA
    Surgery; 2008 Oct; 144(4):525-31; discussion 531-2. PubMed ID: 18847635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of axillary reverse mapping nodes in patients with node-positive breast cancer.
    Noguchi M; Inokuchi M; Yokoi-Noguchi M; Morioka E; Haba Y
    Eur J Surg Oncol; 2023 Oct; 49(10):106937. PubMed ID: 37302899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced Ultrasound Using Intradermal Microbubble Sulfur Hexafluoride in Non-invasive Axillary Staging in Breast Cancer: Are we Missing a Chance?
    Vanni G; Materazzo M; Lorenzo ND; Tacconi F; Pellicciaro M; Berretta M; Mauro GD; Pistolese CA; Noce A; Longo B; Cervelli V; Buonomo OC
    Anticancer Res; 2024 May; 44(5):2021-2030. PubMed ID: 38677765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node involvement--a predictor for axillary node status with breast cancer--has the time come?
    Koller M; Barsuk D; Zippel D; Engelberg S; Ben-Ari G; Papa MZ
    Eur J Surg Oncol; 1998 Jun; 24(3):166-8. PubMed ID: 9630852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study.
    Jannink I; Fan M; Nagy S; Rayudu G; Dowlatshahi K
    Ann Surg Oncol; 1998 Jun; 5(4):310-4. PubMed ID: 9641451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.